BioLamina and Novo Nordisk Partner to Advance Stem Cell Based Therapies for Three Common Medical Conditions – PR Newswire (press release)
|
BioLamina and Novo Nordisk Partner to Advance Stem Cell Based Therapies for Three Common Medical Conditions
PR Newswire (press release) BioLamina and collaborators have partnered with Novo Nordisk A/S (Novo Nordisk), a Danish multinational pharmaceutical company, allowing Novo Nordisk to develop novel stem cell based therapies based on Biolaminins, human recombinant laminin cell … Duke-NUS, Novo Nordisk Join Hands to Study and Develop Stem Cell-based Therapy for Heart and Eye Diseases |
